A mathematical model of tuberculosis transmission with heterogeneity in disease susceptibility and progression under a treatment regime for infectious cases

Applied Mathematical Modelling

Volumn 37, Issue 10-11, 2013, Pages 6786-6808

  Okuonghae, D ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Genetic; Heterogeneity; Mathematical model; Self cure; Treatment; Tuberculosis

Indexed keywords

GENETIC; HETEROGENEITY; SELF CURE; TREATMENT; TUBERCULOSIS;

GENES; MATHEMATICAL MODELS;

TUBES (COMPONENTS);

EID: 84878201152     PISSN: 0307904X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apm.2013.01.039     Document Type: Article

References (48)

1. Murphy B.M., Singer B.H., Anderson S., Kirschner D. Comparing epidemic tuberculosis in demographically distinct heterogeneous populations. Math. Biosci. 2002.
2. Murphy B.M., Singer B.H., Kirschner D. On treatment of tuberculosis in heterogeneous populations. J. Theor. Biol. 2003, 223:391-404.
3. D. Snider Jr, M. Raviglione, A. Kochi, in: B. Bloom (Ed.), Global Burden of Tuberculosis, 16, 1994, pp. 3.
4. Reichman L., Tanne J.H. Timebomb: The Global Epidemic of Multi-drug-resistant Tuberculosis 2002, McGraw Hill, New York, NY.
5. Okuonghae D., Aihie V. Case detection and direct observation therapy strategy (DOTS) in Nigeria: its effect on TB dynamics. J. Biol. Syst. 2008, 16(1):1-31.
6. Okuonghae D., Korobeinikov A. Dynamics of tuberculosis: the effect of direct observation therapy strategy (DOTS) in Nigeria. Math. Modell. Nat. Phenom. 2007, 2(1):113-128. (Epidemiology).
7. Okuonghae D., Omosigho S.E. Analysis of a mathematical model for tuberculosis: what could be done to increase case detection. J. Theor. Biol. 2011, 269:31-45.
8. Ani A., Bruvik T., Okoh Y., Agaba P., Agbaji O., Idoko J., Dahle U. Genetic diversity of Mycobacterium tuberculosis complex in Jos, Nigeria. BMC Infect. Dis. 2010, 10:189.
9. World Health Organization, Global tuberculosis control-surveillance, planning, financing, WHO Report, 2009.
10. Abel L., Casanova J. Clinical predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance. Am. J. Hum. Genet. 2000, 67(2):274-277.
11. Bloom B.R., Small P.M. The evolving relation between humans and Mycobacterium tuberculosis. New Engl. J. Med. 1998, 338:677-678.
12. Chan E.D., Iseman M.D. Current medical treatment for tuberculosis. Br. Med. J. 2002, 325:1282-1286.
13. Cohn D.L., Catlin B.J., Peterson K.L., Judson F.N., Sbarbaro J.A. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen. Ann. Intern. Med. 1990, 112:407-415.
14. Chaulk C.P., Friedman M., Dunning R. Modeling the epidemiology and economics of directly observed therapy in Baltimore. Int. J. Tuberc. Lung. Dis. 2000, 4:201-207.
15. McGrill University Health Centre, First Genetic Resistance factor against Tuberculosis Infection Identified, December 3, 2009.
16. Kramnik I., Dietrich W., Demant P., Bloom B. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. PNAS 2000, 97(15):8560.
17. Goldfeld A., Delgado J., Thim S., Bozon M., Uglialoro A., Turbay D., Cohen C., Yunis E. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998, 279(3):26.
18. Selvaraj P., Uma H., Reetha A., Kurian S. HLA antigen profile in pulmonary tuberculosis patients and their spouses. Indian J. Med. Res. 1998, 107:155-158.
19. Bellamy R., Hill A. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr. Opin. Immunol. 1998, 10:483.
20. Bellamy R., Ruwende C., Corrah T., McAdam K., Whittle H., Hill A. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. New Engl. J. Med. 1998, 338(10):640-644.
21. Hill A. The immunogenetics of human infectious diseases. Ann. Rev. Immunol. 1998, 16:593.
22. Stead W.W. Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering?. Ann. Intern. Med. 1992, 116:937-941.
23. Greenwood C.M.T., Fujiwara T.M., Boothroyd L.J., Miller M.A., Frappier D., Fanning E.A., Schurr E., et al. Linkage of tuberculosis to chromosome 2q35, including NRAMP1, in a large aboriginal Canadian family. Am. J. Hum. Genet. 2000, 67:405-416.
24. Selvaraj P. Host genetics and tuberculosis susceptibility. Curr. Sci. 2004, 86(1):115-121.
25. Zachary A., Steinberg A., Bias W., Leffell M. The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry. Transplantation 1996, 62(2):272.
26. Singh S.P., Mehra N.K., Dingley H.B., Pande J.N., Vaidya M.C. Human Leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J. Infect. Dis. 1983, 148:676-681.
27. Brahmajothi V., et al. Association of pulmonary tuberculosis and HLA in south India. Tubercle 1991, 72:123-132.
28. Rajalingam R., Mehra N.K., Jain R.C., Myneedu V.P., Pande J.N.J. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. Infect. Dis. 1996, 173:669-676.
29. Ravikumar M., et al. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in South India. Tuber. Lung Dis. 1999, 79:309-317.
30. Selvaraj P., Narayanan P.R., Reetha A.M. Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber. Lung Dis. 1999, 79:221-227.
31. Selvaraj P., Narayanan P.R., Reetha A.M. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patirnts and resistance in female contacts. Indian J. Med. Res. 2000, 111:172-179.
32. Selvaraj P., Chandra G., Kurian S.M., Reetha A.M., Narayanan P.R. Association of vitamin D receptor gene variants of BsmI, ApaI and FokI polymorphisms with susceptibility or resistance to pulmonary tuberculosis. Curr. Sci. 2003, 84:1564-1568.
33. Selvaraj P., Chandra G., Kurian S.M., Reetha A.M., Charles N., Narayanan P.R. NRAMP1 gene polymorphism in pulmonary and spinal tuberculosis. Curr. Sci. 2002, 82:451-454.
34. Bellamy R., et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 1999, 179:721-724.
35. Hsu Schmitz S-F. A mathematical model of HIV transmission in homosexuals with genetic heterogeneity. J. Theor. Med. 2000, 2:285-296.
36. Hsu Schmitz S-F. Effects of Treatment or/and vaccination on HIV transmission in homosexuals with genetic heterogeneity. Math. Biosci. 2000, 167:1-18.
37. Castillo-Chavez C., Song B. Dynamical models of tuberculosis and their applications. Math. Biosci. and Eng. 2004, 1(2):361-404.
38. Feng Z., Castillo-Chavez C., Capurro A.F. A model for tuberculosis with exogenous reinfection. Theor. Pop. Biol. 2000, 57:235.
39. Cohen T., Colijn C., Finklea B., Murray M. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J.R. Soc. Interface 2007, 4:523-531.
40. Gomes M.G., Franco A.O., Gomes M.C., Medley G.F. The rein- fection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc. R. Soc. London, Ser. B. 2004.
41. Borgdorff M.W. New measurable indicator for tuberculosis case detection. Emerg. Infect. Dis. 2004, 10(9):1523-1528.
42. Borgdorff M.W., Floyd K., Broekmans J.F. Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries. Bull. World Health Organ. 2002, 80:217-227.
43. K. Styblo and J.R. Bumgarner. Tuberculosis can be controlled with existing technologies: evidence, The Hague: Tuberculosis Surveillance Research Unit, 1991, pp. 60-72.
44. Lakshmikantham V., Leela S., Martynyuk A.A. Stability Analysis of Nonlinear Systems 1989, Marcel Dekker, Inc., New York and Basel.
45. Hethcote H.W. The mathematics of infectious diseases. SIAM Rev. 2000, 42(4):599-653.
46. van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002, 180:29-48.
47. UNAIDS-WHO, UNAIDS/WHO Epidemiological Fact Sheet, 2004. http://www.unaids.org.
48. Dye C., Garnett G.P., Sleeman K., Williams B.G. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998, 352:1886-1891.